#34 Brexit has allowed the UK to vastly improve the speed of rollout of new medical treatments
By leaving the EU the UK has been able to streamline the testing and approval of new medical treatments for use, without impacting patient risk and care. This is only possible due to leaving the EU and its EMA oversight.